About Pharmaron
Pharmaron is a company based in Beijing (China) founded in 2003 by Larry Lou, Bei Zheng, and Boliang Lou.. Pharmaron has raised $320 million across 5 funding rounds from investors including HHS, CITIC Capital and Legend Capital. The company has 476 employees as of December 31, 2021. Pharmaron has completed 6 acquisitions, including Absorption, Aesica and Allergan. Pharmaron operates in a competitive market with competitors including Lonza, Pfizer, Boehringer Ingelheim, LabConnect and Ainos, among others.
- Headquarter Beijing, China
- Employees 476 as on 31 Dec, 2021
- Founders Larry Lou, Bei Zheng, Boliang Lou
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$320 M (USD)
in 5 rounds
-
Latest Funding Round
$280 M (USD), Private Equity Round
Dec 14, 2015
-
Investors
HHS
& 5 more
-
Employee Count
476
as on Dec 31, 2021
-
Investments & Acquisitions
Absorption
& 5 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Pharmaron
Pharmaron has successfully raised a total of $320M across 5 strategic funding rounds. The most recent funding activity was a Private Equity Round round of $280 million completed in December 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Private Equity Round — $280.0M
-
First Round
First Round
(20 Sep 2008)
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2015 | Amount | Private Equity Round - Pharmaron | Valuation | Legend Capital | |
| Mar, 2011 | Amount | Series C - Pharmaron | Valuation | Gl-investment | |
| Sep, 2009 | Amount | Grant - Pharmaron | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Pharmaron
Pharmaron has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, CITIC Capital and Legend Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture Capital firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
Tech-focused seed, early, and mid-stage VC investments are made globally.
|
Founded Year | Domain | Location | |
|
PE firm investing in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Pharmaron
Pharmaron has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include Absorption, Aesica and Allergan. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Full service, early phase CRO specializing in complex trials
|
2006 | ||||
|
Contract development and manufacturing organisation (CDMO) for APIs and finished dose forms
|
2004 | ||||
|
Accelerator Mass Spectrometry is utilized by Xceleron for pharmaceutical analysis.
|
1997 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Pharmaron
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pharmaron Comparisons
Competitors of Pharmaron
Pharmaron operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lonza, Pfizer, Boehringer Ingelheim, LabConnect and Ainos, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
CDMO services for pharma, biotech, and specialty ingredients are provided.
|
|
| domain | founded_year | HQ Location |
Pharmaceutical products for treating multiple diseases are provided.
|
|
| domain | founded_year | HQ Location |
Generic drugs and clinical research services are provided globally.
|
|
| domain | founded_year | HQ Location |
Laboratory testing, clinical trial research, and biopharma services are provided.
|
|
| domain | founded_year | HQ Location |
Novel point-of-care testing and low-dose interferon therapeutics are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Pharmaron
Frequently Asked Questions about Pharmaron
When was Pharmaron founded?
Pharmaron was founded in 2003 and raised its 1st funding round 5 years after it was founded.
Where is Pharmaron located?
Pharmaron is headquartered in Beijing, China.
Who is the current CEO of Pharmaron?
Boliang Lou is the current CEO of Pharmaron. They have also founded this company.
Is Pharmaron a funded company?
Pharmaron is a funded company, having raised a total of $320M across 5 funding rounds to date. The company's 1st funding round was a Grant of $818.32K, raised on Sep 20, 2008.
How many employees does Pharmaron have?
As of Dec 31, 2021, the latest employee count at Pharmaron is 476.
What does Pharmaron do?
Founded in 2003 and headquartered in Beijing, China, Pharmaron operates in the pharmaceutical sector, focusing on research and development services for small molecules, nucleosides, nucleotides, peptides, lipids, and carbohydrates. Disciplines covered include chemistry, biology, DMPK, pharmacology, toxicology, and formulation development. Expertise encompasses organic synthesis, medicinal chemistry, biologics engineering, protein expression, and purification. Acquisitions of Xceleron and SNBL CPC have expanded the service portfolio.
Who are the top competitors of Pharmaron?
Pharmaron's top competitors include Pfizer, Lonza and Boehringer Ingelheim.
How many acquisitions has Pharmaron made?
Pharmaron has made 6 acquisitions, including Absorption, Aesica, and Allergan.
Who are Pharmaron's investors?
Pharmaron has 6 investors. Key investors include HHS, CITIC Capital, Legend Capital, DCM, and Aisling Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.